Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 45,929 |
|
|||||
| News | - | ||||||
| Day High | 1.50 | Low High |
|||||
| Day Low | 1.37 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Context Therapeutics Inc | CNTX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.02 | 1.44% | 1.41 | 16:00:02 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.40 | 1.37 | 1.50 | 1.41 | 1.39 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 235 | 45,929 | $ 1.44 | $ 66,042 | - | 0.47 - 1.69 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:12:45 | 6 | $ 1.39 | USD |
Context Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 22.51M | 15.97M | - | 0 | -23.96M | -1.50 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Context Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CNTX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.34 | 1.60 | 1.34 | 1.49 | 79,957 | 0.07 | 5.22% |
| 1 Month | 1.16 | 1.60 | 1.06 | 1.34 | 101,968 | 0.25 | 21.55% |
| 3 Months | 0.96 | 1.60 | 0.89 | 1.25 | 58,891 | 0.45 | 46.88% |
| 6 Months | 1.30 | 1.60 | 0.77 | 1.18 | 50,482 | 0.11 | 8.46% |
| 1 Year | 0.659 | 1.69 | 0.47 | 1.08 | 75,365 | 0.751 | 113.96% |
| 3 Years | 4.44 | 10.87 | 0.47 | 3.94 | 830,440 | -3.03 | -68.24% |
| 5 Years | 4.44 | 10.87 | 0.47 | 3.94 | 830,440 | -3.03 | -68.24% |
Context Therapeutics Description
| Context Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to improving the lives of women living with cancer. The development team is advancing a pipeline of innovative therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. |
